High Tower Advisors, LLC Genprex, Inc. Call Options Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	BUY	$1.82 - $3.5 $109 - $210	60 New	60 $3,000
Q4 2020 Feb 10, 2021	SELL	$3.03 - $5.51 $54,540 - $99,180	-18,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.9 - $4.29 $49,300 - $72,930	-17,000 Reduced 48.57%	18,000 $22,000
Q2 2020 Aug 10, 2020	BUY	$1.99 - $3.64 $58,705 - $107,380	29,500 Added 536.36%	35,000 $27,000
Q1 2020 May 21, 2020	BUY	$0.28 - $6.23 $1,540 - $34,265	5,500 New	5,500 $2,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.